SBWire

GlobalData's clinical trial report, "Endometriosis Global Clinical Trials Review, H2, 2012" provides data on the Endometriosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endometriosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Endometriosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Argentina Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others" provides key market data on the Argentina Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Fetal Monitors, Micro-Electromechanical Systems, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Patient Monitoring Accessories and Remote Patient Monitoring. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Bangladesh. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields and refineries) in Bangladesh. The report compares the investment environment in Bangladesh with other countries in the region. The profiles of the major companies operating in the crude oil sector in Bangladesh together with the latest news and deals are also included in the report.

GlobalData's new report, "Insulin Delivery Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" provides key market data on the Insulin Delivery market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within four market categories - Insulin Pens, Insulin Syringes, Traditional Insulin Pump Accessories and Insulin Pumps. The report also provides company shares and distribution shares data for the overall Insulin Delivery market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

GlobalData's clinical trial report, "Pre-Eclampsia Global Clinical Trials Review, H2, 2012" provides data on the Pre-Eclampsia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pre-Eclampsia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pre-Eclampsia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Hydropower (Large and Small Hydro, and Pumped Storage) in Mexico, Market Outlook to 2025 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the hydropower market in Mexico. The report provides in depth analysis on global renewable power market and global hydropower market with forecasts up to 2025. The report analyzes the power market scenario in Mexico (includes thermal conventional, nuclear, large hydro and renewables) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro, biopower and solar PV) and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in Mexico hydropower market. The research analyzes investment trends and LCOE for small hydropower in Mexico during 2011-2025. The report provides information on the amount of carbon saved and average number of homes powered by hydropower during 2001-2025. A detailed coverage of renewable energy policy framework governing the market with specific policies pertaining to hydropower is provided in the report. The research also provides company snapshots of some of the major market participants.

The culture of consumerism is reasonably well entrenched in Malaysia given its relatively high consumption levels. As the lower and middle classes in Malaysia reap the benefits of the country's rapid economic development, the trend of premiumisation is expected to gather pace over the coming years. We expect stronger growth prospects in the higher-value food categories such as confectionery and functional foods. The halal food sector is also expected to achieve particularly robust dynamism as more companies expand their product offerings beyond non-halal products to capture burgeoning domestic and export opportunities.

BMI's India Defence & Security Report for Q1 2013 examines the country's strategic position in the Asian region and the wider world. It also provides an overview of the contemporary geopolitical challenges facing the country, and the challenges it may face in the future.

BMI's Bulgaria Petrochemicals Report assesses the trends that will affect the country's relatively small petrochemicals base. It also examines the impact of the business environment on investors' risk management strategies and the chances of capacity growth over the medium-term.

Global Markets Direct's, 'Pruritus - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Pruritus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pruritus. Pruritus - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Oropharyngeal Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oropharyngeal Cancer. Oropharyngeal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma). Systemic Sclerosis (Scleroderma) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Alcohol Addiction - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Alcohol Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alcohol Addiction. Alcohol Addiction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "ImClone LLC - Product Pipeline Review - 2012" provides data on the ImClone LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Skin Ulcers - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Skin Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Ulcers. Skin Ulcers - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Menopausal Disorders - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Disorders. Menopausal Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Diabetic Foot Ulcers - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Foot Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Foot Ulcers. Diabetic Foot Ulcers - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

This report is the result of SDI's extensive market and company research covering the Chilean defense industry, and provides detailed analysis of both historic and forecast defense industry values including key growth stimulators, analysis of the leading companies in the industry, and key news.

GBI Research, the leading business intelligence provider, has released its latest research, "Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)", which provides insights into the global ophthalmology therapeutics market, with forecasts until 2018. The report provides an in-depth analysis of the key therapeutic indications of ophthalmology, namely glaucoma, allergic conjunctivitis, Dry Eye Syndrome (DES), Diabetic Macular Edema (DME), and Wet Age Macular Degeneration (Wet-AMD). The report also examines the ophthalmology therapeutics treatment usage patterns for the covered indications. In addition, the report includes insights into the ophthalmology R&D pipeline.

GlobalData's new report, "South and Central America Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the South and Central America Diagnostic Imaging market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

GlobalData's new report, "Europe Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the Europe Diagnostic Imaging market - France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Global Market Direct's pharmaceuticals report, "GTC Biotherapeutics, Inc. - Product Pipeline Review - 2012" provides data on the GTC Biotherapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Catabasis Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Catabasis Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "CalAsia Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the CalAsia Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Nyken BV - Product Pipeline Review - 2012" provides data on the Nyken BV's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.